The acknowledgment of having a child with potential genetic disorders or malformations is not only experienced by the CFTR-carrier women, who represented the main focus of the study, but also by those who acknowledge that their pregnancy is at risk and require invasive diagnostic procedures. This evidence concerns the gene CFTR and hereditary disease.